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BACKGROUND AND STUDY AIM: To develop a molecular imaging endoscopic system that eliminates tissue
autofluorescence and distinguishes multiple fluorescent markers specifically on the cancerous lesions.
METHODS: Newly developed multi-spectral fluorescence endoscope device has the potential to eliminate signal
interference due to autofluorescence and multiplex fluorophores in fluorescent probes. The multiplexing capability
of the multi-spectral endoscope device was demonstrated in the phantom studies and multi-spectral imaging with
endoscopy and macroscopy was performed to analyze fluorescence signals after administration of fluorescent
probe that targets cancer in the colon. Because of the limitations in the clinical application using rigid-type small
animal endoscope, we developed a flexible channel insert-type fluorescence endoscope, which was validated onand the grant supported by the Ministry of Trade, Industry & Energy (MOTIE, Korea)
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Translational Oncology Vol. 12, No. 2, 2019 Bae et al. 227the colonoscopy of dummy and porcine model. RESULTS: We measured multiple fluorescent signals
simultaneously, and the fluorescence spectra were unmixed to separate the fluorescent signals of each probe,
in which multiple fluorescent probes clearly revealed spectral deconvolution at the specific targeting area in the mouse
colon. The positive area of fluorescence signal for each probe over the whole polyp was segmented with analyzing
software, and showed distinctive patterns and significantly distinguishable values: 0.46 ± 0.04, 0.39 ± 0.08 and
0.73 ± 0.12 for HMRG, CET-553 and TRA-675 probes, respectively. The spectral unmixing was finally demonstrated in
the dummy and porcine model, corroborating the targeted multi-spectral fluorescence imaging of colon dysplasia.
CONCLUSION: The multi-spectral endoscopy system may allow endoscopists to clearly identify cancerous lesion that
has different patterns of various target expression using multiple fluorescent probes.
Translational Oncology (2019) 12, 226–235Introduction
Colorectal cancer is one of the most common cancer diagnosed, and
has been the second leading cause of cancer death [1]. Early detection
of colorectal cancer can prevent cancer progression and increase
chances of survival. Screening colonoscopy aided by white light
illumination currently performed for early detection to identify and
remove polypoid adenomas for preventing cancer development and
progression [2,3]. However, some malignant polyps are flat in
architecture and patchily distributed, resulting in limited detection of
early stage tumors in patient undergoing adenoma-carcinoma
sequence [4,5]. Distinguishing the changes between the normal and
dysplastic tissue depends thoroughly on the expertise of endoscopists,
thus it is hampered by empirical decision on obscure lesions that are
hardly discriminative by naked eye [6,7].
The significant problem to detect true signal spectra of ‘smart’
molecular reagents labeled with fluorophore in vivo is that the spectra
are always admixed with autofluorescence signals [8,9]. There are two
major methods to remove tissue autofluorescence in in vivo imaging:
utilizing fluorescence lifetime information and removing tissue
autofluorescence is by using multispectral imaging (MSI). The
former is needed expensive pulsed lasers and the latter has lower cost
and higher speed than the former [9].
Recent advances in gastrointestinal endoscopy have resulted in new
imaging methods that improve the detection capability of early
neoplastic lesions [10–12], such as narrowband and autofluorescence
imaging, nonspecific contrast mechanisms are still challenging.
Potential uses of fluorescent agents have been demonstrated to
monitor molecular changes [13] and therefore visualize molecular
changes specific for colorectal cancer in vivo and, as a result, indicate a
distinguishable region [14,15]. Multiple probes enable specific
targeting and verification of the cancer-related cellular changes, and
further confer reliable assurance for cancer diagnosis. The fluorescent
signals of each targeting probe is typically measured and analyzed by
multi-spectral imaging devices, and recently equipped with endosco-
py system [8,10,14–19]. However, conventional imaging systems
suffer from limited sensitivity to fluorescent spectral overlap and
deconvolution [19].
Here we introduce a home-built instrument for multi-fluorescent
imaging and demonstrate the capability of spectral unmixing with
various fluorophore dyes. The multi-spectral endoscopy system is
equipped with a liquid crystal tunable filter (LCTF), in whichmultiple fluorophores that have spectral overlap can be sharply
separated by using multiband acquisition [20]. Moreover, LCTF
excludes tissue autofluorescence, thus improves contrast by decreasing
target-to-background ratio to make the inspected target clearly
discriminated [9,21]. It has been widely reported that EGFR [22–26]
and HER2 are abundantly expressed in the tumor, thus the
antibodies that are labeled with fluorescent dyes become fluorescent
probe for detection of these receptors [27–29]. The integrated
imaging system is then validated to visualize individual dysplasia in a
colon cancer mouse model with administration of multiple
fluorescent probes that target the polyps. To measure and quantify
the effective fluorescence signal, which eliminated background and
autofluorescence by unmixing, the signal of each probe was subjected
to threshold segmentation through inform software (PerkinElmer,
Hopkinton, MA). Finally, we combined the multi-spectral imaging
system to channel insert-type endoscope, and performed the
colonoscopy in the porcine model to verify the potential clinical
application.
Methods
Multi-Spectral Fluorescence and White Light Imaging
Endoscope System
The imaging system is composed of a 0°cysto-urethroscope (Karl Storz,
Tuttlingen, Germany), multi-spectral imaging system (Nuance FX,
PerkinElmer, Hopkinton, MA), sensitive color charge-coupled device
(CCD) camera (QIClick, QImaging, Surrey, BC, Canada), and
achromatic lenses as depicted Figure 1A. A rigid type cysto-
urethroscope probe (HOPKINS II Telescope 27301AA, Karl Storz,
Tuttlingen, Germany) is coupled to both cameras via the beam splitter,
which functions as channels for white light and fluorescent excitation
source. Singlet lens collimate the light to the cameras, and the light
transmits to both CCD detector in the camera and the Nuance camera
(1392 × 1040 pixels). The excitation energy is generated by 300-W
Xenon lamp (MAX-303, Asahi Spectra, Torrance, CA) with band-pass
filters (480/30 nm, 540/25 nm and 679/41 nm) that excites fluorophores
of corresponding fluorescent probes.
The Nuance Imaging Module was built in a single compact
package containing the principal imaging components: scientific-
grade CCD imaging sensor, liquid crystal tunable filter (LCTF)
which has a scanning range between 420 and 720 nm with a polarizer,
Figure 1. Setup of multi-spectral endoscope and phantom study. (A) Design and fabrication of multi-spectral endoscope. Detection of
white light image was performed by CCD camera and fluorescent image by Nuance camera. The collected images or fluorescence signal
is divided in beam splitter and passes through each lens in front of two CCD camera. The excitation light which is generated from xenon
lamp goes into endoscopic channel and excites fluorophores of fluorescent probes. (B) Demonstration of multiplexing on phantom study
with a polyethylene mock-up tube, which was attached to metal ring (Left upper). (Lower) Each unmixed signal is seen with (Left lower)
and without (Right lower) pseudo-color. The bare-eyed reflection image is shown in the figure (Reflection RGB, middle lower). The graph
represents emission spectra of each dyes (Upper Right).
228 Bae et al. Translational Oncology Vol. 12, No. 2, 2019a very narrow band-pass (± 5 to 20 nm) and wavelength tuning
element. Nuance acquisition software (PerkinElmer, Hopkinton,
MA) was developed along with the imaging system to capture and
analyze the multi-spectral images.
The sample exposure time for the Nuance camera was adjusted from
200 ms to 800 ms depending on the sample brightness. A series of
fluorescence images at different wavelengths were rapidly acquired by the
Nuance CCD camera and the data was assembled into a spectral data
“cube” for analyzing fluorescence spectra in a few seconds.
Spectral Unmixing, Autofluorescence Elimination And Imaging
Analysis
For the spectral unmixing in the inspected tissues, we established a
“Spectral Library” using negative and positive control subjects. Acquiringthe Spectral Library was as follows: 1) Selecting cube wavelengths for
emission scan for the fluorescent probes, 2) Determining optimal
exposure time for the subject to observation adjusting exposure time so as
not to saturate (below 60,000 counts), 3) Acquiring one “ImageCube”
after sequentially taking multispectral image stacks from the emission
planes which are collected according to excitation light, and 4) Creating a
Spectral Libraries in a file from negative and positive control groups.
Spectral unmixing is executed with sophisticated algorithms (RCA: real
component analysis) of Nuance software. Then the targeted fluorophores
from administered probes can be separated from every component in the
acquisition through the use of spectral subtraction and negative controls.
Using the morphologic segmentation analysis software “inForm”
(PerkinElmer), the positive area of fluorescence signal in polyp was
segmented and analyzed. The software was trained to recognize polyp area
Translational Oncology Vol. 12, No. 2, 2019 Bae et al. 229with “Trainable Tissue Segmentation” in the software and scored the
percentage of the occupied fluorescence signal.
Phantom Study
Phantom study was performed with a polyethylene (PE-10) mock-
up tube (15 mm long, 0.28 mm inner diameter), which was attached
to metal ring (Figure 1B). Each polyethylene tube was filled with
fluorescent dye solutions that has broad range of fluorescence spectra,
and measured in the range from 420 nm to 620 nm with 5 nm step.Figure 2. Ex vivo colon tissue imaging with multispectral endoscope
vivo experiments. Mouse is administered with fluorescence probes an
targeted ex vivo colon polyp images from mouse treating with single
scanned for IVIS wide-field fluorescence imaging (B) and imaged with
of white-light (W/L) and IVIS optical fluorescence-light (F/L) imaging
(spraying) sequentially results in separate spatial patterns of bindin
follows: 520–560 nm (five planes, 10 nm scan step), 600–640 nm (five
step). The composite unmixed images of single-probe-treated polyp sh
480/30 nm for green, 540/25 nm for red and 679/41 nm for skyblue ps
under all excitation light.The fluorescent dyes used here were as following: Flamma-496 (Ex/
Em 496/516 nm), Flamma-507 (Ex/Em 507/532 nm), Flamma-530
(Ex/Em 530/558 nm), Flamma-553 (Ex/Em 554/584 nm), Flamma-
560 (Ex/Em 560/589 nm), Flamma-575 (Ex/Em 578/606 nm) and
Flamma-581 (Ex/Em 578/595 nm). Multiple fluorophores was
sequentially excited with blue excitation (480 nm) and green
excitation (525 nm) from LED light source (TouchBrightLED,
Seoul, South Korea) under the exposure time condition of 900 ms in
the emission range of 420 nm to 530 nm and 500 ms in the emissionand IVIS system. (A) An illustrated flow showing the performed ex
d examined by optical instrument and MSI-endoscopy. Individually
probe only and triple probes simultaneously. Excised colons were
multi-spectral fluorescence endoscope system (C). The whole view
of colon is shown (B). Apply of two antibodies (i.v.) and HMRG
g to colonic dysplasia. The wavelength of emission planes is as
planes, 10 nm scan step) and 690–720 nm (four planes, 10 nm scan
owed respective signal under the excitation with band-pass filter of
eudocolor and triple-probe-treated polyp showed all positive signal
Figure 3. In vivo real-time multispectral endoscopic imaging and ex vivo imaging. (A) An illustrated flow showing the performed in real-
time in vivo and ex vivo experiments. Mouse is administered with fluorescence probes and examined by multi-spectral endoscopy and
macroscopy. (B) In vivo fluorescence image of polyps using separately administered probes gGlu-HMRG (HMRG), Cetuximab (CET-553)
and Trastuzumab (TRA-675). The white light image of inspected polyp is shown at the end to the left. (C) The colon from fig. (B) was
resected from the examined mouse and inspected with multi-spectral macroscopy. The whole view (Photo) and macroscopic
monochrome image (Monochrome) of colon are shown in the top of column. The macroscopic fluorescence images show different
patterns of signal at each spectrum. The white arrow indicates the inspected polyp shown in vivo.The composite unmixed images of
single-probe-treated polyp showed respective signal under the excitation with band-pass filter of 480/30 nm for green, 540/25 nm for red
and 679/41 nm for skyblue pseudocolor and triple-probe-treated polyp showed all positive signal under all excitation light. (D) Threshold
segmentation of multiple fluorophores using inform software and positive area of fluorescence signal in polyp quantification. (E) H&E
histology of polyp shows features similar to those seen in sporadic human adenomas. (F) Confocal microscopy images showing binding
of fluorescence probe to colon tissue. Biopsies tissue were excised after in vivo administration of probes and images were collected.
Untreated colon polyp was shown as control.
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Figure 3 (continued).
Translational Oncology Vol. 12, No. 2, 2019 Bae et al. 231range of 530 nm to 620 nm, respectively. The assembled spectral data
were utilized to separate specific fluorescence labels over the tissue
autofluorescence.
AOM/DSS Mouse Model of Polypoid Adenomas
Five-week-old male BALB/c mice were used for inflammation-
driven colonic tumorigenesis utilizing a single injection of AOM
followed by 2 seven-day cycles of DSS over a 8 week period.
Azoxymethane (AOM, 10 mg/kg body weight; Sigma–Aldrich,
MO, USA) is intraperitoneally injected on day 0 and at the beginning
of the second week (day 7), dextran sodium sulfate solution (DSS,
2%; MP Biomedicals, Illkirch, France) is administered to mice in
their drinking water. Seven days of DSS is followed by 2 weeks of
switching back a basal diet and tap water. Another additional 1 cycle
of DSS are administered, and tumor formation in the colonic wall was
examined with colonoscopy. All animal experiments were performed
with protocols approved by the Institutional Animal Care and Use
Committee (IACUC) of the Asan Institute for Life Sciences, Asan
Medical Center. The committee abides by the Institute of Laboratory
Animal Resources (ILAR) guide.
Preparation of Fluorescence Molecular Probes
We adopted monoclonal antibody cetuximab (Erbitux; Merck KGaA,
Darmstadt, Germany) and trastuzumab (Herceptin; Roche, Basel,
Switzerland) for its interaction with EGFR and HER2, respectively. Anactivatable probe, γ-glutamyl hydroxymethyl rhodamine green (gGlu-
HMRG), is another agent to detect the cancerous lesions. This probe is
rapidly activated by γ-glutamyltranspeptidase (GGT) which is over-
expressed on the cell membrane of various cancer, but is not expressed in
normal tissue [30,31].
gGlu-HMRG was prepared according to the synthesis of references
[32] by BioActs (Incheon, Korea) and monoclonal antibodies were
conjugated with fluorescent dyes (Flamma-553 NHS ester, Flamma-
675 NHS ester, respectively) according to the company's protocol.
Endoscopic Imaging of Colon Ex Vivo And In Vivo
AOM/DSS mice model (age over 15 weeks old) were used for
imaging. Conventional white light endoscopy was executed for
screening and identifying the presence of polyps in the mice colon.
Due to the pharmacodynamics of the antibody probe, it accumulates
persistently in the target of the tumor and takes a certain amount of
time to be released from surrounding normal tissue. We performed
preliminarily a controlled experiment to determine the optimized
time point for acquiring good target-to-background ratio by
examining in experimental mice after injecting the antibody probe.
The targeting probes (CET-553 and TRA-675) were administered in
the mice via tail vein injection, 2 days before the endoscopic imaging.
Mice were fasted over 8 hours, and stool in the colon was removed by
a saline lavage for spaying of the activatable probe HMRG. The
HMRG was intrarectally administrated by instilling with disposable
Figure 4. In vivo real-time multispectral endoscopic imaging with channel insert-type endoscope device in porcine. (A) Schematic of
channel insert-type endoscope designed to be inserted through the accessory channel of a clinical sigmoidoscope with a 3.2-mm
instrument channel. The enlarged frontal view of imaging scope (Upper left), distal end of sigmoidoscope (Upper right) and the whole
view of channel insert-type endoscope (Lower) is presented (DM: Dichroic mirror, MMF: Multi-mode fiber). (B) White-light endoscopic
screenshot of making pseudo polyp (i-ii) and illuminating on the colon wall of porcine in the state of white-light mode (iii) and fluorescence
mode (iv). (C) Multi-spectral fluorescent imaging with fluorescent dye sample and unmixing imaging. The activated form of HMRG after
mixed with GGT in advance, Flamma-553 and Flamma-675 dyes or/and all three mixed dye was infused onto the colon wall of porcine.The
images represented that single dye-infused polyp showed respective signal under the excitation with band-pass filter of 480/30 nm for
green, 540/25 nm for red and 679/41 nm for skyblue pseudocolor and triple-probe-treated polyp revealed all positive signal at all spectra.
The last column to the left shows a monochrome image collected at 540 ± 40 for Non-treat and HMRG group, 620 ± 40 for CET-553
group and 705 ± 30 for TRA-675 group respectively.
232 Bae et al. Translational Oncology Vol. 12, No. 2, 2019zonde and incubated for 5 minutes. For ex vivo endoscopy, the colon
was excised and incised to expose the lumen of colon. The colon
tissue was laid down on a flat plate, and faced to the tip of small
animal endoscope. For in vivo imaging, the mice were anesthetized byinhaling isoflurane gas mixed with oxygen, and the colon was
insufflated with CO2 gas. The colon was monitored through the
CCD camera and the multi-spectral imaging was conducted if polys
were detected. Xenon lamp was used as a light source at designated
Translational Oncology Vol. 12, No. 2, 2019 Bae et al. 233excitation wavelength with band-pass filters of 480/30 nm, 540/25
nm and 679/41 nm (Asahi Spectra, Torrance, CA). The individual
excitation for emission planes of “ImageCube” is as follows: 480/30
BP excitation with five planes (520, 530, 540, 550 and 560 nm),
540/25 BP excitation five planes (600, 610, 620, 630 and 640 nm)
and 679/41 BP with four planes (690, 700, 710 and 720 nm).
Ex Vivo Fluorescence Optical and Macroscopic Imaging
The excised colon tissues were then moved into the IVIS Spectrum
system (PerkinElmer, Hopkinton, MA) and the fluorescence signal
was collected. The excitation/emission wavelengths for HMRG,
CET-553 and TRA-675 were 465/520 nm, 554/584 nm and 675/
691 nm, respectively under auto acquisition setup. For macroscopic
inspection, Nuance was attached to the MacroFluo Z16 APO
macroscope (Leica) and operated by the Nuance software.
Imaging with Channel Insert-Type Endoscope System for
Multi-Spectral Fluorescent Imaging
Specific details of the channel insert-type endoscope system are
described in the literature [33] and schematic is shown in Figure 4A.
Briefly, the device is fabricated with flexible and miniaturized fiber-
optic probe for the compatibility with clinical endoscope in non-
contact mode. The imaging scope consists of a micro lens attached to a
leached fiber bundle and multimode fibers (NA 0.55, SCHOTT AG)
for delivering excitation light using an achromatic VIS–NIR-coated
lens with an effective focal length (EFL) of 18 mm. Excitation light
was delivered from the same xenon lamp used in rigid type endoscope
of previous mouse studies and the fluorescence light from reflection
and emission are collected via a micro-lens and relayed back to the
optical path by the image scope. The light passes through two
achromatic lenses with EFLs of 10 and 40 mm (Edmund Optics),
LCTF of Nuance, and a dichroic mirror. The reflection image is
captured by a CCD camera (QIClick, QImaging) and fluorescence
images are acquired sequentially with scientific-grade CCD camera of
Nuance. We demonstrated the multi-spectral fluorescent imaging of
the channel insert-type endoscope both in the simulated dummy
colon model and the porcine colon to validate sigmoidoscopic
feasibility in the clinic. To mimic the polyp bearing accumulated
fluorescent probes, we produced dye-agar droplets (2% agar, 5–6 mm
size), which were made by mixing agar and each three fluorescent dyes
(FITC, Flamma-553 and Flamma-675) and solidified as stiff gel. The
dye-agar droplets were attached on the wall of dummy colon model
and endoscopic imaging was performed.
For in vivo validation of channel insert-type endoscope system, we
used a porcine colon of Yorkshire pig weighing 30 kg. The pig was
anesthetized with 4% isoflurane for induction and maintained with
1.5 ± 2% by continuous inhalation through endotracheal intubation.
We created pseudo polyps comprising the fluorescence dye onto the
colon wall using a clinical injection needle (NM-400U-0423,Olympus).
Each fluorescent dye (2 mg/ml) and the activated form of HMRG (51
mU GGT+ 50uM HMRG) probes were individually injected to the
polyps, or their mixture (300 μl) was simultaneously introduced. The
animal studies were performed under the supervision of the IACUC of
the Asan Medical Center by the approved institutional protocols.
Histological Evaluation
The localization of each fluorescent probe in resected colon tissues of
mice, along with the morphology, were evaluated by histological analysis.
Excised colon tissues of mice were fixed with 10% formalin, and 1)embedded in paraffin or 2) frozen in OCT medium, followed by
section into slices. Paraffin-sectioned slices were stained with H&E using
common procedure. Cryo-sectioned tissue slices were stained with 4,6-
diamidino-2-phenylindole (DAPI) for nuclei, slide-mounted, and sealed.
Samples were pictured by a conventional eclipse microscopy or a confocal
microscopy (Carl Zeiss, Inc., Jena, Germany).
Results
The ability of multi-spectral endoscope device equipped with the
Nuance camera was firstly performed with a phantom study as shown
in Figure 1B. Polyethylene tubes filled with fluorescent dyes of
different emission band edges were located at the end of telescope
probe, and the emission spectra were simultaneously measured. To
execute spectral unmixing, we obtained the intrinsic emission spectra
of each dye, and then used as reference to separate the overlapped
emission spectra (spectral unmixing). The pseudo color images of
unmixed emission signals represent highly enhanced spectral
difference of each fluorescent dye, compared to the reflection image
shown in naked eye (Reflection RGB).
To assess the ability of multi-spectral fluorescence endoscope
device to multiplex ex vivo, two probes (CET-553 and TRA-675)
were two days before and one probe (HMRG) was just prior to mouse
sacrifice administered (Figure 2A). The whole colon tissue was spread
on a flat plate and investigated by the multi-spectral fluorescence
endoscope. Figure 2C shows the representative fluorescence endo-
scopic images of the colon tissues, in which each targeting probe have
been introduced. Polypoid lesion of non-treated group at the first row
in Figure 2C showed specular reflection from surface of dysplasia and
seen as a false positive signal due to the close distance between the
dampish tissue of colon polyps and the end of the telescope.
However, specific fluorescence signals were detected in the targeting
probe-treated groups: HMRG at 540/40, CET-553 at 620/40 and
TRA-675 at 705/30. The results support that each targeting probe
enabled to home the cancerous lesion in the colon, and the fluorescence
signal of each probe was clearly distinguishable in different emission
band.These spectra informationwere collected as a spectrum library, and
accordingly used as a reference for spectral unmixing in the following
validation. We next applied three targeting probes simultaneously. The
fluorescence images revealed positive signals for all targeting probes,
suggesting that three probes have certain specific interactions with the
polyps. Interestingly, the targeted areas of each probe showed slightly
different shape, particularly in CET-553, possibly due to variation
of the receptors overexpressed even in a cancerous polyp. The
cetuximab-positive epidermal growth factor receptor (EGFR)
seemed to be slowly overexpressed than the trastuzumab-positive
HER2, otherwise there was difference in the targeting efficacy between
cetuximab and trastuzumab at one polyp. To verify the multi-spectral
targeting, we then imaged the whole colon with a conventional
fluorescence imaging system, IVIS (Figure 2B). The antibody-treated
mice showed significant fluorescence signals at the polypoid lesion of
the colon while negligible in the normal colon. However, since there is
variation from differences between individual mice and number of
polyps in a mouse colon, the comparison of fluorescence intensity at the
polypoid lesion between each probe treatment group is not
significant. The results clearly support the targeting specificity of
cetuximab and trastuzumab to the lesions. The activatable probe
showed strong fluorescence signals at both polypoid lesions and the
margins between polyps of adjacent normal mucosa. Especially, it
will not be irrelevant to the characteristics of spray-type probe that
234 Bae et al. Translational Oncology Vol. 12, No. 2, 2019some of the remaining HMRG probes appear as a partial accumulation
in the margin area.
We next demonstrated in vivo endoscopic imaging from the colon
of AOM/DSS mouse model. Administration of three fluorescence
probes was carried out in advance in the same way as ex vivo
experiment (Figure 3A). We obtained the images of colon using the
multi-spectral fluorescence endoscopy system in the single probe-
treated group (Supplementary Figure S1), and then used the spectral
information as a spectral library data for unmixing process of multiple
fluorescence signals. The fluorescence images of live mice colon
also showed clearly distinguishable lesions via fluorescence signals
(Figure 3B). Corresponding to the ex vivo study, the multiple
targeting probes designated the fluorescent lesions over normal colon
tissue. Acquired fluorescence spectra were sufficiently separated by
unmixing in the Nuance software. To validate the fluorescence signals
on polyps of colon in macroscopic view, we facilitated the Nuance
camera module with macroscopy and imaged the corresponding
colon tissue after sacrifice of mice (Figure 3C). In the i.v.-
administered Ab group, a strong signal was seen in the polyp, and
in the spraying-administered HMRG group, the signal was seen not
only in the polyp but also in the adjacent normal mucosa of colon
wall. The macroscopic imaging of the single probe-treated group was
performed (Supplementary Figure S2). The images showed distinct
fluorescence at the lesions, corresponding to the above results. In
addition, we designated the regions of interest (ROI) for the target-
signal (Ts) and the whole polyp (Tp), and then calculated the positive
area of fluorescence signal in polyp. Using the inform analysis,
we obtained the positive area of fluorescence signal in polyp that
appeared as segmentation and the Ts/Tp ratio: 0.46 ± 0.04
(HMRG), 0.39 ± 0.08 (CET-553) and 0.73 ± 0.12 (TRA-675),
respectively (Figure 3D). This segmentation and quantification of
target-intensity may allow the clinician to determine the type and
dosage of medicine to apply to the patient for follow up treatment.
The corresponding lesion was evaluated with histology (hematoxylin
and eosin (H&E) staining) and showed dysplasia, characterized by
crypt distortion and nuclear enlargement (Figure 3E). Confocal
microscopy images of biopsied tissue collected subsequent to probe
administration represented that the probe signal was mostly appeared
on probe-treated polyp, but not on probe-treated adjacent colon
wall and probe-untreated polyp (Figure 3F). To validate the fluorescence
signal, we scanned the whole colon of single and triple probe-treated
groupwith IVIS wide-field fluorescence imaging system (Supplementary
Figure S3).
For the clinical application of multi-spectral fluorescent endoscopy
system, the channel insert-type endoscope was equipped with the
sigmoidoscope (Figure 4A). The imaging system was connected to the
Nuance module, and applied to simulated dummy colon model
(Supplementary Figure S4) and the porcine colon (Figure 4B) to
investigate the clinical suitability with the sigmoidoscope. A video
showing real-time imaging of performance for the multi-spectral
fluorescence endoscopic system with the channel insert-type endoscope
is provided in Supplementary Video 1. The end of channel insert-type
endoscope is shown to approach near to the dye-agar droplets on thewall
of simulated dummy model. The last video segment shows the
conversion of imaging mode from white light to fluorescence flashing
dye-agar droplets.
Finally, we adopted the imaging system for tumor surveillance in
the pseudo polyp on the colon wall of porcine model where the
fluorescent probes were infused on purpose (Figure 4B (i-ii)). Multi-spectral fluorescent imaging was then performed, and showed clearly
distinguishable area of the probe infusion (Figure 4B (iii-iv)). White
light video in Supplementary Video 2 is shown for the real-time
imaging of producing blister-like pseudo polyps by injection of
fluorophores. The fluorescence signals of HMRG mixed with GGT,
Flamma-553 and Flamma-675 dyes showed well-defined spectral
unmixing in the present system, and their mixture was also
simultaneously displayed with the respective signal at the corre-
sponding emission peak band (Figure 4C).
Discussion
Here, we report a multi-spectral fluorescent endoscopy system that can
clearly separate multiple fluorescent spectra probes to visualize the
individual probe via spectral unmixing. The fluorescent probes were
introduced both systemically and topically to the mouse colon, followed
by imaging in vivo and ex vivo. To achieve this multi-spectral fluorescent
imaging, the emission spectra need to be appropriately separated one-by-
one, thus an endoscopic device to unmix various fluorescent probes is a
key demand. The required specifications are likely to fulfill the capabilities
of unmixing different emission spectrum of each probe and eliminating
intrinsic autofluorescence which distracts the probe signals particularly in
the gastrointestinal tract [9].
We performed multi-spectral endoscopic imaging for the polyps
ex vivo and in vivo, accompanied by conventional fluorescence
imaging instrument for macroscopic point of view. Specific targeting
of each fluorescent probe was confirmed by clear distinction via spectral
unmixing. In the future, this technology will enable to visualize tumor
heterogeneity for understanding the tumor characters including
anticancer drug responsiveness.
In addition, the multi-spectral imaging system can be used for
monitoring clonal evolution of individual progenitors. The system
can examine unique spatial patterns of gene overexpression by
differentiating individual target gene, and provide a potential tool for
studying epigenetic and environmental factors that influence cancer
formation. This can be further applied to perform personalized
image-guided therapy. While three channels were executed in the
present study, the optical design can be adapted for using more
fluorescent dyes, as we showed very sensitive spectral unmixing in the
visible to near-infrared regime (Figure 1B). Present study is the first
report on an endoscope-compatible instrument that can concurrently
image multiple molecular probes in different spectral regimes over the
usage mostly in the field of conventional microscopy.
Endoscopic imaging of mouse colon has been performed with
rigid-type small animal endoscope, however we developed the multi-
spectral imaging system, compatible to flexible channel insert-type
endoscope for clinical use as a translational medical device. The
flexible fluorescence endoscopic system can be applied for molecular
diagnosis along with conventional white-light colonoscopy to identify
flat dysplasia lesions.
Our system, on the other hand, has a limitation related to low
transmission for fluorescence emission light of LCTF which is
typically 30%-range compared to conventional filters (~90%) [34].
Low transmittance results in relatively the drawback of requiring long
exposure times for acquiring image.
However, LCTF has great capability of using multiple filters
rapidly with fast movement between filters, resulting in remarkable
signal-to-noise ratio through the spectral unmixing process. There-
fore, it is expected that problems will be overcome if the LCTF which
has the disadvantage of transmittance is substituted for a single filter
Translational Oncology Vol. 12, No. 2, 2019 Bae et al. 235and a conventional filter system which has the disadvantage of
switching between filters is substituted for a high-speed filter wheel.
We are developing the multi-spectral fluorescence endoscope with
high performance filter wheel bearing unmixing algorithm, thus
this will lead to improved early cancer detection for appropriate
treatments for patient.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.tranon.2018.10.006.
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